According to a new market report published by Lucintel, the future of the Swiss diagnostic imaging market looks promising with opportunities in the public hospitals, private hospitals, and imaging centers. The Swiss diagnostic imaging market is expected to reach an estimated $0.6 billion by 2027 with a CAGR of 4.5% from 2022 to 2027. The major drivers for this market are increasing healthcare expenditure and awareness associated with early diagnosis of disease.
Browse 53 market data tables and 59 figures spread through 138 pages and in-depth TOC on “Swiss Diagnostic Imaging Market"
In this market X-ray, CT scan, MRI, ultrasound, mammography, and nuclear imaging systems are the major product type of diagnostic imaging. On the basis of comprehensive research, Lucintel forecasts that X-ray systems will remain the largest segment due to increasing aging population, technological and infrastructural developments, and the rising prevalence of lifestyle-related diseases.
Within the Swiss diagnostic imaging market, public hospitals and private hospitals & imaging centers are the major end users of diagnostic imaging. Private hospitals and imaging centers will remain the largest end use market due to increasing number of diagnostic imaging centers and rise in prevalence of chronic diseases.
Emerging trends which have a direct impact on the dynamics of the market include usage of advanced combination imaging procedures and introduction of computer-aided designs. Koninklijke Philips N.V., Siemens AG, Guerbet, Canon, General Electric Company, Shimadzu Corporation, Fujifilm, Konica Minolta, Pristem SA, and Josef Betschart AG are among the major suppliers of diagnostic imaging.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the Swiss diagnostic imaging market by product, application, and end use, and has compiled a comprehensive research report entitled “Growth Opportunities in the Swiss Diagnostic Imaging Market 2022-2027.” The Lucintel report serves as a catalyst for growth strategy by providing comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the Swiss diagnostic imaging market by product, application, and end use, as follows:
By Product [Value ($ Million) from 2016 to 2027]:
•X-ray Systems
oBy Technology
?Computed Radiography
?Direct Radiography
?Analog Imaging
oBy Portability
?Stationary Devices
?Portable Devices
•Computed Tomography (CT) Scan Systems
oHigh-end Slice
oMid-end Slice
oLow-end Slice
•Magnetic Resonance Imaging (MRI) Systems
oBy Architecture
?Closed MRI Devices
?Open MRI Devices
oBy Field Strength
?Low-to-mid-field Systems
?High-field Systems
?Very-high-field Systems
?Ultra-high-field Systems
•Ultrasound Systems
oBy Technology
?2D Imaging
?3D and 4D Imaging
?Doppler Imaging
oBy Portability
?Trolley/Cart-based Devices
?Compact/Portable Devices
•Mammography System
oDigital Imaging
oAnalogy Imaging
•Nuclear Imaging Systems
oSPECT (Single-photon Emission Computed Tomography) Nuclear Imaging
oHybrid PET (Photon Emission Tomography) Nuclear Imaging
By Application [Value ($ Million) from 2016 to 2027]:
•Cardiology
•Respiratory
•Neurology
•Orthopedic
•Oncology
•Obstetrics and Gynecology
•Gastroenterology
•Others
By End User [Value ($ Million) from 2016 to 2027]:
•Public Hospital
•Private Hospitals and Imaging Centers
This 138-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/swiss-diagnostic-imaging-market.aspx or write us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.
This report addresses the following key questions:
Q.1. What are some of the most promising, high-growth opportunities for the Swiss diagnostic imaging market by product (X-ray systems, CT (computerized tomography) scan systems, MRI (magnetic resonance imaging) systems, ultrasound systems, mammography systems, and nuclear imaging systems), application (cardiology, respiratory, neurology, orthopedic, oncology, obstetrics and gynecology, gastroenterology, and others), end user (public hospitals and private hospitals & imaging centers)?
Q.2. Which product segment will grow at a faster pace and why?
Q.3. What are the key factors affecting market dynamics? What are the drivers, challenges, and business risks in this market?
Q.4. What are the business risks and competitive threats in this market?
Q.5. What are the emerging trends in this market and the reasons behind them?
Q.6. What are some of the changing demands of customers in the market?
Q.7. What are the new developments in the market and which companies are leading these developments?
Q.8. Who are the major players in this market? What strategic initiatives are being taken by key companies for business growth?
Q.9. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by product substitution?